Predict your next investment

Prolacta Bioscience company logo
HEALTHCARE | Drug Manufacturing / Vitamins, Supplements & Nutraceuticals
prolacta.com

See what CB Insights has to offer

Founded Year

1999

Stage

Series E | Alive

Total Raised

$81.22M

Last Raised

$8.91M | 3 yrs ago

About Prolacta Bioscience

Prolacta Bioscience is a privately held life sciences company dedicated to Advancing the Science of Human Milk. The company pioneered the development of human milk-based neonatal nutritional products to meet the needs of critically ill, premature infants in the NICU. Prolacta leads the industry in the quality and safety of nutritional products made from donor breast milk, and operates the first and only pharmaceutical-grade manufacturing facility for the processing of human milk.

Prolacta Bioscience Headquarter Location

1800 Highland Ave.

Duarte, California, 91010,

United States

626-599-9260

Latest Prolacta Bioscience News

09:07 ET Prolacta Bioscience's Mindy Fuzesy Presents at Association of Women's Health, Obstetric and Neonatal Nurses 2021 Virtua...

Oct 11, 2021

Session Addressed the Importance of Bioactivity in Human Milk-Based Products for Premature and Critically Ill Infants in the NICU News provided by Share this article Share this article DUARTE, Calif., Oct. 11, 2021 /PRNewswire/ -- Prolacta Bioscience ®, the world's leading hospital provider of 100% human milk-based nutritional products for premature and critically ill infants, announced that Mindy Fuzesy, RNC-NIC, RNC-OB, MSL-BC presented at the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) virtual convention on Sunday, October 10, at 4 p.m. ET. The presentation, titled "Magic in Every Drop: The Bioactivity of Human Milk," addressed the important role bioactivity plays in the human milk-based products that hospitals use to provide vital nutrition to fragile patients in neonatal intensive care units (NICUs). Mindy Fuzesy, RNC-NIC, RNC-OB, MSL-BC, and medical science liaison of neonatal and pediatric nursing at Prolacta Bioscience "Human milk is more than nutrition for premature and critically ill infants — it is medicine," said Fuzesy, medical science liaison of neonatal and pediatric nursing at Prolacta. "The bioactive components found in human milk are essential for supporting immunity, development, growth, and the long-term health of premature and critically ill infants.1 It's important that we have discussions about how manufacturing processes influence the retention of bioactive components in donor human milk." Breast milk naturally contains bioactive components that are critical for infants' health.1 However, once the milk is processed and/or pasteurized to ensure safety, bioactivity is impacted.2,3 Some human milk processing methods, such as Prolacta's patented vat pasteurization process, retain more of the natural bioactivity of the milk than other processes.2-4 This yields donor human milk and donor milk products that more closely reflect mother's own milk.3,4 Each year, the AWHONN convention brings together the leaders in the fields of women's health, obstetrics, and neonatology to discuss emerging research and topics to advance learning and education in their fields. To learn more, please visit https://www.awhonnconvention.org/ . About Prolacta Bioscience Prolacta Bioscience® Inc. is a privately held, global life sciences company dedicated to Advancing the Science of Human Milk® to improve the health of premature and critically ill infants. Prolacta's 100% human milk-based nutritional products have been evaluated in more than 20 clinical studies published in peer-reviewed journals. More than 70,000 premature infants have benefited from Prolacta's nutritional products worldwide to date.5 Established in 1999, Prolacta is the world's leading provider of human milk-based nutritional products for hospital use and is also exploring the therapeutic potential of human milk across a wide spectrum of diseases. Prolacta maintains the industry's strictest quality and safety standards for screening, testing, and processing human donor milk. Operating the world's first pharmaceutical-grade human milk processing facilities, Prolacta uses vat pasteurization and a patented, FDA-reviewed manufacturing process to ensure pathogen inactivation while protecting the nutritional composition and bioactivity of its human milk-based products. Prolacta is a global company with headquarters in Duarte, California, and can be found online at www.prolacta.com , on Twitter , Instagram , Facebook  and LinkedIn . Media Contact: References 1. Gila-Diaz A, Arribas SM, Algara A, Martín-Cabrejas MA, López de Pablo ÁL, Sáenz de Pipaón M, Ramiro-Cortijo D. A review of bioactive factors in human breastmilk: a focus on prematurity. Nutrients. 2019;11(6):1307. doi:10.3390/nu11061307 2. Meredith-Dennis L, Xu G, Goonatilleke E, Lebrilla CB, Underwood MA, Smilowitz JT. Composition and variation of macronutrients, immune proteins, and human milk oligosaccharides in human milk from nonprofit and commercial milk banks. J Hum Lact. 2018;34(1):120-129. doi:10.1177/0890334417710635 3. Lima HK, Wagner-Gillespie M, Perrin MT, Fogleman AD. Bacteria and bioactivity in holder pasteurized and shelf-stable human milk products. Curr Dev Nutr. 2017;1(8):e001438. doi:10.3945/cdn.117.001438 4. Internal Data 5. Estimated number of premature infants fed Prolacta's products from January 2007 to May 2021; data on file. SOURCE Prolacta Bioscience

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Prolacta Bioscience

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Prolacta Bioscience is included in 4 Expert Collections, including Vitamin & Supplement Startups.

V

Vitamin & Supplement Startups

625 items

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

C

Consumer Packaged Goods ( CPG )

4,148 items

F

Food & Beverage

2,628 items

Prolacta Bioscience Patents

Prolacta Bioscience has filed 32 patents.

The 3 most popular patent topics include:

  • Breastfeeding
  • Milk
  • Neonatology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/5/2014

9/21/2021

Milk, Neonatology, Breastfeeding, Nutrition, Pediatrics

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

3/5/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

9/21/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Milk, Neonatology, Breastfeeding, Nutrition, Pediatrics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Prolacta Bioscience Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Prolacta Bioscience Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.